Immunogenomics conference Sept 26-28

Huntsville, Ala. ━ HudsonAlpha Institute for Biotechnology will bring together more than 150 leading researchers from around the world on Sept. 26-28, 2016 at the 4th annual HudsonAlpha Immunogenomics conference.

Immunogenomics lies at the intersection of immunology and genomics and explores the ways in which the human genome interacts with disease.

Conference speakers include Jian Han, MD, PhD, a HudsonAlpha faculty investigator and founder of associate company and conference sponsor IRepertoire; along with keynote speakers Herbert Virgin, MD, PhD, from Washington University School in St. Louis, MO and Alan Aderem, PhD, from the University of Washington in Seattle.

Han is a pioneer in immunogenomics and runs the Repertoire 10,000 (R10K) project at HudsonAlpha. The goal of the R10K project is to develop a simple, low-cost and accurate method to determine a patient’s health index and use that test to analyze the health indices of 10,000 people. Han will present during the Immunogenomics and Immunotherapy session. He also is a conference organizer and has been involved with the event since its inception.

“Everything is related to the immune system,” said Han. “Our immune system is the smartest and best doctor around and if we can learn from the best, we can be better.”

Devin Absher, PhD, a HudsonAlpha faculty investigator, is also a conference organizer and has been involved with the event since its inception.

“Immunogenomics has become a world class conference and the sessions this year are outstanding,” said Absher. “The HudsonAlpha campus, designed for collaboration, is a great venue for an event like this. Everyone who comes here is impressed with the facility design, the extensive scientific research and the discoveries made here.”

HudsonAlpha president and science director Richard Myers, PhD, said conferences such as Immunogenomics are important for not only sharing science and growing collaboration, but also to showcase HudsonAlpha, Huntsville and North Alabama.

“Our campus itself houses several dozen life science companies, and is located in one of the largest research parks in the country,” Myers said. “The researchers who attend the conference, spend time at HudsonAlpha, tour the area and dine under the Saturn V rocket are very impressed with all we have to offer, and we want them to share those experiences when they return home. We enjoy seeing them return to the Immunogenomics conference as well.”

View the Immunogenomics 2016 program at If you would like to engage in this multi-day program of science talks and network with the key players in the immunogenomics field, register at

Immunogenomics 2016 is sponsored by: Bay City Capital, Yonglin Healthcare, iRepertoire, Illumina and Merck.

About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to innovating in the field of genomic technology and sciences across a spectrum of biological challenges. Opened in 2008, its mission is four-fold: sparking scientific discoveries that can impact human health and well-being; bringing genomic medicine into clinical care; fostering life sciences entrepreneurship and business growth; and encouraging the creation of a genomics-literate workforce and society. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. Designed to be a hothouse of biotech economic development, HudsonAlpha’s state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. The relationships formed on the HudsonAlpha campus encourage collaborations that produce advances in medicine and agriculture. Under the leadership of Dr. Richard M. Myers, a key collaborator on the Human Genome Project, HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education, and includes more than 30 diverse biotech companies on campus. To learn more about HudsonAlpha, visit: